Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II in Refractory Distributive Shock
NCT06351150Phase 3Recruiting
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Angiotensin II in Distributive shock (DS), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jul 2024; status: recruiting.
02
Drugs
Angiotensin II
03
Conditions
Distributive shock (DS)
Beyond the preview
Go deeper on NCT06351150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06351150.